COVID-19 Vaccine

• CDC/IDSA COVID-19 Clinician Calls Weekly Series - Saturdays at noon PST. 1/23/21 Ask the Expert: Vaccine Q&A with Sara Oliver, MD, Co-Lead, COVID-19 Work Group of the Advisory Committee on Immunization Practices, CDC Register for Webinars
• Pfizer Training Sessions Series - Webinars are twice daily every weekday at 7am and 2pm PST through January 15. WebEx links and codes

View recorded webinars

DPH Resources

• Vaccine information for the publicwebpage: includes FAQs, vaccine myths, and vaccine scams. Patients can also sign up to receive email newsletters with vaccine updates. Materials are available in multiple languages.
• Vaccine Distribution in Los Angeles County webpage– explains how decisions about vaccination are made and lists the phases and tiers of vaccine distribution EnglishSpanish

CDC Resources - Answering patients’ questions about COVID-19 vaccine:

• Engaging in Effective COVID-19 Vaccine Conversations webpage
  • Techniques for effective conversations webpage
  • Tips and sample scripts of how to answer likely questions webpage
  • Common Questions People May Ask Healthcare Professionals 2 page handout
  • Patient FAQs

FDA Resources

• Vaccine EUA fact sheets for recipients and caregivers PfizerModerna

• COVID-19 Winter Surge & Vaccine Rollout - Is Hope on the Horizon?: 1-19-21 Virtual Grand Rounds host by the California Health and Human Services Agency (CHHS) and the California Medical Association (CMA). covidroundsca.org.
• COVID Conversations 1-13-21 Focuses on logistics of distribution and administration of the vaccine in California, as well as prioritization and allocation strategies. Hosted by the California Immunization Coalition in partnership with the American Academy of Pediatrics-California Recording
• CDC COCA Call: COVID-19 Vaccines: Update on Allergic Reactions, Contraindications, and Precautions 12-30-20 Slides Recording
• LAC DPH: COVID Vaccination rollout for FQHC's and Community Clinics 12-29-20 Recording (requires password: AhRkAu8c)
• CDC COCA Call: What Clinicians Need to Know About the Pfizer-BioNTech and Moderna COVID-19 Vaccines 12-18-20  Slides Recording
• ASCO/IDSA Webinar: The COVID-19 Vaccine & Patients with Cancer  12-17-20 Recording
• CDC COCA Call: What Every Clinician Should Know about COVID-19 Vaccine Safety - 12-14-20 Slides, Recording.
• LAC DPH COVID-19 Vaccine Preparation Checklist for Acute Care Hospitals 12-9-20.  Recording (requires password: TpbsZ6uM)
• IAC webinar with CDC Speakers COVID-19 Vaccination Implementation and the “Vaccinate with Confidence Strategy” 12-3-20 Recording & Slides

Vaccine Administration Provider Line -Questions about vaccine distribution, storage and handling, and guidance on registering to receive the vaccine through the CDPH enrollment website.

• Monday through Friday, 8:00am- 5:00pm call 833-505-0761 or email COVIDVaccineReq@ph.lacounty.gov.

Vaccine Clinical Provider Line –Clinical questions about COVID-19 vaccines including but not limited to contraindications, precautions, side effects, post vaccination assessment

• Monday through Friday, 8:00am-5:00pm, call 213-240-7941. For time-sensitive questions after hours, call 213-974-1234 and ask for the on-call clinician

Medical professionals interested in supporting the COVID-19 response:

• Paid positions - contact the California COVID Health Corps
• Volunteer opportunities (including Medical Disaster Service Workers) - contact the City of Los Angeles

Vaccine trial data and information from FDA are below:

Pfizer-BioNTech

• Walsh et al. Safety and immunogenicity of two RNA-Based COVID-19 vaccine candidates. NEJM 2020; online publication Oct 14.
• Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints Press Release 11-18-20
• Phase 3 trial information 12-10-20 New England Journal of Medicine Safety and Efficacy of the BNT162b2 Covid-19 Vaccine  Editorial  Video summary
• Pfizer vaccine: CDC webpage  FDA webpage (includes fact sheets for Healthcare Providers and  Recipients and Caregivers in 20 languages)

Moderna

• Jackson et al. An mRNA Vaccine against SARS-CoV-2-Preliminary report. NEJM 2020;20:1920-1931.
• Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate Press Release 11-30-20
• Moderna vaccine: CDC webpage  FDA webpage(includes fact sheets for Healthcare Providers and  Recipients and Caregivers in multiple languages)